Medical economics

Groups make own drugs to fight high drug prices, shortages

Impatient with years of inaction in Washington on prescription drug costs, U.S. hospital groups, startups and nonprofits have started making their own medicines in a bid to combat stubbornly high prices and persistent shortages ...

Medications

Dutch watchdog fines Italian drug company for surcharge

Italian pharmaceutical Leadiant has been fined almost 20 million euros for allegedly overcharging for medicine used to treat a rare cholesterol disease, the Dutch consumer watchdog said on Monday.

page 5 from 22